Clinical Chemistry
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Clinical Chemistry 0: clinchem.2006.074237v1, 2006; 10.1373/clinchem.2006.074237
This Article
Right arrow Full Text (PDF)
Right arrow 074237.Supplemental data
Right arrow All Versions of this Article:
clinchem.2006.074237v1
53/2/300    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Øiestad, E. L.
Right arrow Articles by Christophersen, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Øiestad, E. L.
Right arrow Articles by Christophersen, S.

Received on May 30, 2006
Accepted on November 3, 2006

Automation and Analytical Techniques

Drug Screening of Preserved Oral Fluid by Liquid Chromatography-Tandem Mass Spectrometry

Elisabeth Leere Øiestad 1*, Unni Johansen 1, Solberg Christophersen 1

1 Norwegian Institute of Public Health, Division of Forensic Toxicology and Drug Abuse, Oslo, Norway

* To whom correspondence should be addressed. E-mail: elisabeth.oiestad{at}fhi.no.

Background: Oral fluid is an alternative matrix with potential applications in road-side drug screening, work-place testing, drug treatment programs, and epidemiological surveys. Development of methods for extensive drug screening in oral fluid is warranted.

Methods: We developed a liquid chromatography- tandem mass spectrometry (LC-MS/MS) method for drug screening of preserved oral fluid collected with the Intercept® collection device. Samples were prepared by liquid-liquid extraction with ethylacetate/heptane (4:1). LC-separation was achieved with an Atlantis dC18-column (2.1 x 50 mm, 3 µm particle). Mass detection was performed by positive ion mode electrospray LC-MS/MS and included the following drugs/metabolites: morphine, 6-monoacetylmorphine, codeine, buprenorphine, methadone, amphetamine, methamphetamine, 3,4-methylenedioxymethamphetamine, 3,4-methylenedioxyamphetamine, 3,4-methylenedioxyethylamphetamine, cocaine, benzoylecgonine, {Delta}-9-tetrahydrocannabinol, lysergic acid diethylamide, alprazolam, bromazepam, clonazepam, 7-aminoclonazepam, diazepam, N-desmethyldiazepam, 3-OH-diazepam, fenazepam, flunitrazepam, 7-aminoflunitrazepam, lorazepam, nitrazepam, 7-aminonitrazepam, oxazepam, zopiclone, zolpidem, carisoprodol, and meprobamat.

Results: Screening of 32 drugs was performed with a run time of 14 min. Within- and between-day relative CVs varied from 2.0% to 31.8% and from 3.6% to 39.1%, respectively. Extraction recoveries were >50% except for morphine (30%) and benzoylecgonine (0.2%). The concentrations of the lowest calibrator were 1 nmol/L (0.28 µg/L) to 500 nmol/L (68 µg/L), depending on the drug.

Conclusion: The method allowed rapid and sensitive oral fluid screening for the most commonly abused drugs in Norway and will be used for a road-side survey of drug use in normal traffic.




The following articles in journals at HighWire Press have cited this article:


Home page
Clin. Chem.Home page
W. M. Bosker and M. A. Huestis
Oral Fluid Testing for Drugs of Abuse
Clin. Chem., November 1, 2009; 55(11): 1910 - 1931.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
N. Badawi, K. W. Simonsen, A. Steentoft, I. M. Bernhoft, and K. Linnet
Simultaneous Screening and Quantification of 29 Drugs of Abuse in Oral Fluid by Solid-Phase Extraction and Ultraperformance LC-MS/MS
Clin. Chem., November 1, 2009; 55(11): 2004 - 2018.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Copyright © 2006 by the American Association for Clinical Chemistry.